Tag:
KNS-760704
Latest Headlines
Latest Headlines
Biogen pays $80M to buddy up on PhIII ALS program
Biogen Idec is buddying up to Knopp Neurosciences with $80 million in cash and up to $245 million more in various milestones for marketing rights to a promising, late-stage ALS drug. Biogen will
